Leuthold Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.12M | Buy |
43,445
+687
| +2% | +$52.9K | 0.33% | 113 |
|
|
2025
Q4 | $3.39M | Buy |
42,758
+141
| +0.3% | +$11.1K | 0.37% | 110 |
|
|
2025
Q3 | $3.21M | Buy |
42,617
+1,477
| +4% | +$101K | 0.35% | 107 |
|
|
2025
Q2 | $2.84M | Buy |
+41,140
| New | +$2.7M | 0.34% | 111 |
|
|
2023
Q1 | – | Sell |
-44,563
| Closed | -$4.15M | – | 203 |
|
|
2022
Q4 | $4.15M | Sell |
44,563
-1,475
| -3% | -$142K | 0.56% | 71 |
|
|
2022
Q3 | $4.39M | Buy |
+46,038
| New | +$4.56M | 0.66% | 58 |
|
|
2021
Q4 | – | Sell |
-46,689
| Closed | -$3.96M | – | 205 |
|
|
2021
Q3 | $3.96M | Buy |
46,689
+148
| +0.3% | +$12.4K | 0.49% | 82 |
|
|
2021
Q2 | $3.88M | Sell |
46,541
-875
| -2% | -$71.7K | 0.48% | 77 |
|
|
2021
Q1 | $3.57M | Sell |
47,416
-9,269
| -16% | -$675K | 0.45% | 83 |
|
|
2020
Q4 | $3.87M | Sell |
56,685
-2,399
| -4% | -$156K | 0.51% | 72 |
|
|
2020
Q3 | $3.45M | Sell |
59,084
-1,208
| -2% | -$75.2K | 0.47% | 74 |
|
|
2020
Q2 | $3.92M | Sell |
60,292
-1,595
| -3% | -$100K | 0.58% | 66 |
|
|
2020
Q1 | $3.67M | Buy |
61,887
+56,306
| +1,009% | +$3.76M | 0.66% | 54 |
|
|
2019
Q4 | $415K | Buy |
+5,581
| New | +$392K | 0.05% | 131 |
|
|
2019
Q2 | – | Sell |
-120,019
| Closed | -$6.47M | – | 193 |
|
|
2019
Q1 | $6.47M | Sell |
120,019
-4,222
| -3% | -$261K | 0.87% | 37 |
|
|
2018
Q4 | $8.14M | Buy |
+124,241
| New | +$9.27M | 1.17% | 24 |
|
|
2016
Q2 | – | Sell |
-119,996
| Closed | -$12.4M | – | 215 |
|
|
2016
Q1 | $12.4M | Buy |
119,996
+2,380
| +2% | +$231K | 1.36% | 8 |
|
|
2015
Q4 | $11.5M | Buy |
117,616
+5,448
| +5% | +$534K | 1.21% | 13 |
|
|
2015
Q3 | $10.8M | Sell |
112,168
-13,993
| -11% | -$1.47M | 1.14% | 14 |
|
|
2015
Q2 | $13.2M | Sell |
126,161
-76,071
| -38% | -$7.77M | 1.24% | 9 |
|
|
2015
Q1 | $20.9M | Buy |
202,232
+739
| +0.4% | +$74.8K | 1.94% | 4 |
|
|
2014
Q4 | $19.4M | Sell |
201,493
-43,943
| -18% | -$3.87M | 1.91% | 3 |
|
|
2014
Q3 | $19.5M | Sell |
245,436
-20,782
| -8% | -$1.64M | 1.76% | 4 |
|
|
2014
Q2 | $20.1M | Sell |
266,218
-54,850
| -17% | -$4.15M | 1.7% | 5 |
|
|
2014
Q1 | $24M | Sell |
321,068
-4,081
| -1% | -$288K | 2.13% | 4 |
|
|
2013
Q4 | $23.3M | Buy |
325,149
+25,376
| +8% | +$1.63M | 2.08% | 5 |
|
|
2013
Q3 | $17M | Sell |
299,773
-17,379
| -5% | -$1.04M | 1.57% | 6 |
|
|
2013
Q2 | $18.1M | Buy |
+317,152
| New | +$18.4M | 1.68% | 3 |
|
Other funds holding CVS
VCM
VPM
Leuthold Group's CVS Position: Q1 2026 in Review
Leuthold Group increased its CVS Health (CVS) stake by 1.6% in Q1 2026, buying an estimated $52.9K and bringing the position to 43,445 shares worth $3.12M. The position accounts for 0.33% of the portfolio, ranked #113.
Leuthold Group first reported a position in CVS in Q2 2013 and has held it in 28 quarters since. The position peaked at $24M in Q1 2014. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Leuthold Group held 43,445 shares of CVS Health worth $3.12M as of Q1 2026.
- Leuthold Group bought 687 CVS Health shares in Q1 2026, an estimated $52.9K.
- CVS Health made up 0.33% of Leuthold Group's portfolio in Q1 2026, its #113 holding.
- Leuthold Group first reported a position in CVS Health in Q2 2013 and has held it in 28 quarters since.
- Leuthold Group's CVS Health position peaked at $24M in Q1 2014.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.